Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 25,000 shares at $110.44 ($2.8M) on 2025-06-09, disclosed to the SEC on 2025-06-10.
Scheduled sale ($2.8M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AXSM | SELL | 2026-02-27 | $5.7M | — | Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |